TMEM17 Promotes Tumor Progression in Glioblastoma by Activating the PI3K/AKT Pathway
These data prove that <i>TMEM17</i> plays a key role in the regulation of GBM and has great potential as a clinical therapeutic target for GBM.
Authors
- Quan Zhou (ORCID: https://orcid.org/0000-0002-9351-5614)
- Chang Liu (ORCID: https://orcid.org/0000-0001-8489-2605)
- Sheng Yan (ORCID: https://orcid.org/0000-0001-7795-8725)
- Fujun Li (ORCID: https://orcid.org/0000-0001-6032-1242)
- Maolin He
- Daqin Feng
- Shengyong Wang
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2024-08-16
- DOI
- https://doi.org/10.31083/j.fbl2908285
- Citations
- 7
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.07
Funders
- National Natural Science Foundation of China